NEW YORK (GenomeWeb) – Accelerate Diagnostics said in a regulatory document that its revenues for the first quarter were unchanged year over year at $14,000.

All revenues for the three months ended March 31, as well as for the year-ago quarter, were derived from licensing and royalty revenues, the Tucson, Arizona-based firm said in its Form 10-Q filed with the US Securities and Exchange Commission last week. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.